Point72 Middle East Fze Gilead Sciences, Inc. Put Options Transaction History

Point72 Middle East Fze

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $1.32 Million - $1.5 Million	-18,000 Reduced 39.74%	27,300 $2.21 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $2.33 Million - $2.54 Million	31,500 Added 228.26%	45,300 $3.39 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $813,307 - $927,690	10,700 Added 345.16%	13,800 $1.06 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $1.44 Million - $1.64 Million	-18,600 Reduced 85.71%	3,100 $257,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $1.35 Million - $1.94 Million	21,700 New	21,700 $0

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.